G. Subramanian, Vipan Parihar, D. Sreedhar and M. Sreenivasa Reddy

Abstract: The markets for the traditional output of schools of pharmacy, namely education, research and graduates, are changing. The pharmaceutical industry is moving fast to become more efficient, under pressure from overly costly drug development. The development of safe and effective new therapeutics is a long, difficult, and expensive process. Pharmaceutical education has to set new priorities to keep pace with the challenges related to genomic technologies for the personalized medicine in post genome era. The development of new initiative education programs, for both undergraduate and postgraduate curricula, in pharmacy has to be focused on preparing pharmacists oriented for both pharmacy practice and drug research and development. This can be achieved by providing future pharmacists with knowledge, skills and attitudes to be more competitive in the health care system, pharmacy practice-related fields, pharmaceutical industry and drug research and development areas, or finally in academia. Educators and pharmacy colleges have the responsibility in preparing students to familiar with latest developments in pharmacogenomics and medical bioinformatics for better patient care and cost reduction in the drug development process. The curriculum in Pharmacogenomics, learning sources and the ethical aspects of incorporation of subject are dealt in this article.

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com